IMS Health — Q2 2014 Earnings Presentation
19 slides from IMS Health's earnings presentation, Jul 24, 2014
Slide 1: IMS Health Q2 2014 Earnings Call
IMS Health Q2 2014 Earnings Call July 24, 2014 IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 2: Legal
Legal This presentation should be viewed in conjunction with IMS Health’s Q2 2014 earnings call Safe Harbor Statement This presentation includes “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements rega
Slide 3: 2nd Quarter Results
2nd Quarter Results $M Revenue EBITDA +6.1% +9.2% $662 $226 $624 $206 Q2 2013 Q2 2014 Q2 2013 Q2 2014 Dollars are actual foreign exchange rates. EBITDA is “Adjusted EBITDA” as defined in the IMS Health earnings release IMS Health Confidential. Do not distribute outside your organization. 3 (c) 2014
Slide 4: Progress in the Quarter
Progress in the Quarter Cegedim’s Information Solutions and CRM Businesses Information Technology Services • Healthcare Professionals • CRM SaaS Solutions Database • Compliance Applications • Market Research 42% • Managed Services • Analytics 33% 25% Other(1) 2013 Financials(2) $573M Revenue, $86M A
Slide 5: 2nd Quarter Revenue by Offering
2nd Quarter Revenue Offering 2ndd Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency Information $386 $379 1.8% 1.2% Technology $276 $245 12.7% 12.0% Services Total $662 $624 6.1% 5.4% IMS Health Confidential. Do not distribute outside your organization. 5 (c) 2014 IMS Health Incorpor
Slide 6: 2nd Quarter Revenue by Geography
2nd Quarter Revenue Geography 2nd Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency Developed Markets $543 $515 5.5% 4.4% Emerging Markets $119 $109 8.7% 10.1% Total $662 $624 6.1% 5.4% IMS Health Confidential. Do not distribute outside your organization. 6 (c) 2014 IMS Health Incorp
Slide 7: 2nd Quarter EBITDA
2nd Quarter EBITDA 2nd Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency Adjusted EBITDA $226 $206 9.2% 9.3% Adjusted EBITDA 34.0% 33.1% 97bps 123 bps margin g IMS Health Confidential. Do not distribute outside your organization. 7 (c) 2014 IMS Health Incorporated. All Rights Reserve
Slide 8: Special Items - 2nd Quarter
Special Items - 2nd Quarter 2nd Quarter, $M 2014 IPO related charges: g Sponsor monitoring termination $72 Non executive phantom stock compensation Non-executive $30 Make-whole premiums $151 Non-cash debt issuance & OID write-offs $68 Other charges: Devaluation of Venezuelan Bolivar assets & liabili
Slide 9: 2nd Quarter P&L
2nd Quarter P&L $M (except per share data) 2014 2013 Net (Loss) / Income $(220) $8 Adjusted Net Income $134 $96 Diluted (Loss) / Earnings per Share $(0.67) $0.03 Adjusted Diluted EPS $0.39 $0.33 IMS Health Confidential. Do not distribute outside your organization. 9 (c) 2014 IMS Health Incorporated.
Slide 10: Year-to-date Revenue
Year-to-date Revenue Offering Year-to-date Versus Prior Year Constant $M $ 2014 2013 Reported p C Currency Information $767 $757 1.4% 2.0% Technology $540 $480 12.3% 12.2% S Services i Total $1,307 $1,237 5.7% 6.0% Geography Year-to-date Versus Prior Year Developed Markets $1,075 $1,024 5.0% 4.8% Em
Slide 11: Year-to-date P&L
Year-to-date P&L $M (except per share data) 2014 2013 Adjusted EBITDA $443 $409 Adjusted EBITDA margin 33.9% 33.1% Net (Loss) / Income $(244) $20 Adjusted Net Income $204 $172 Diluted (Loss) / Earnings per Share $(0.80) $0.07 Adj t d Diluted Adjusted Dil t d EPS $0 65 $0.65 $0 60 $0.60 Year-to-date
Slide 12: 2nd Quarter Balance Sheet Items & Metrics
2nd Quarter Balance Sheet Items & Metrics $M 2014 2013 Cash & Cash Equivalents & Short Term $266 $729 ((1)) Investments Gross Debt (2) $3,996 $5,027 (1) Net Debt $3,730 $4,298 (1) Gross Leverage Ratio 4.6x 6.1x (1) Cash (Used in) Provided by Operating $(126) $126 Activities Capital Expenditures and
Slide 13: Q&A
Q&A IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 14: Appendix: Non-GAAP Financial Measures
Appendix: Non-GAAP Financial Measures IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.
Slide 15: Net Income to Adjusted EBITDA
Net Income to Adjusted EBITDA Three Months Ended Six Months Ended June 30, June 30, (in millions) 2014 2013 2014 2013 Net (loss) income $ (220) $ 8 $ (244) $ 20 (Benefit from) provision for income taxes (139) 9 (152) 14 Other loss (income), net(1) 271 6 288 (10) Interest expense 49 75 138 154 Intere
Slide 16: Net Income to Adjusted Net Income & Per Share Data
Net Income to Adjusted Net Income & Per Share Data Three Months Ended Six Months Ended June 30, June 30, (in millions) 2014 2013 2014 2013 Net (Loss) Income $ (220) $ 8 $ (244) $ 20 (Benefit from) provision for income taxes (139) 9 (152) 14 Amortization associated with purchase accounting 77 75 153
Slide 17: Unlevered Free Cash Flow
Unlevered Free Cash Flow Three Months Ended Six Months Ended June 30, June 30, (in millions) 2014 2013 2014 2013 Net Cash (Used in) Provided by Operating Activities $ (126) $ 126 $ (229) $ 124 Capital expenditures (12) (10) (45) (17) Additions to computer software (23) (18) (44) (31) Free Cash Flow
Slide 18: Gross Leverage Ratio
Gross Leverage Ratio (in millions) Gross Debt as of June 30, 2014 $ 3,996 Adjusted EBITDA for the year ended December 31, 2013 829 Less: Adjusted EBITDA for the six months ended June 30, 2013 (409) Add: Adjusted EBITDA for the six months ended June 30 30, 2014 443 Adjusted EBITDA for the twelve mont
Slide 19: END
END IMS Health Confidential. Do not distribute outside your organization. 19 (c) 2014 IMS Health Incorporated. All Rights Reserved.